Nutrición Utilidad del uso de un probiótico en niños desnutridos tratados con antibióticos
Bibliografía
Lilly D, Stillwell R. Probiotcis: Growth promoting factors produced by Microorganisms. Science 1965; 47:747-8.
Fuller R .Probiotics in man and animals. J.Appl Bacteriol 1989; 66:365-378. Comentado en: Am J Clin Nutr 2001; 73: 430S-436s.
Hoyos AB. (1999). Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3: 197-202. Medline. (Consulta: 4 dic. 2004).
Gorbach SL, Chang TW, Goldin B. (1987). Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG .Lancet 2: 1519. Medline. (Consulta: 4 dic. 2004).
McFarland LV, Suwawicz CM, Greenberg RN, et al. (1994). A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271: 1913-8. Abstract
Wunderlich PD, Braun L, Fumagalli I, D-Apuzzo V, Heim F, Karly M, et al. (1989). Double- blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treament of acute diarrhoea. J Int Med Res 117: 333-8. Medline. (Consulta: 4 dic. 2004).
Siitonen S, Vapaatalo J, Salminen S, et al. (1990). Effect of Lactobacillus GG yogurt in prevention of antibiotic-associated diarrhoea. Ann Med 22: 57-9. Medline . (Consulta: 4 dic. 2004).
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. (1999). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135: 564-8. Medline (Consulta: 4 dic. 2004).
Gotz V, Romankiewica JA, Moss J, Murray HW. (1979). Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation. Am J Hosp Pharm 36: 754-7. Medline. (Consulta: 4 dic. 2004).
Silva M, Jacobus N, Deneke C, Gorback S. (1987). Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31:1231-3. Medline. (Consulta: 4 dic. 2004).
Surawicz CM, Elmer Gw, Speelman P, McFarland LV, Chinn J, Van Belle G. (1989).Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96: 981-8. Medline. (Consulta: 4 dic. 2004).
McFarland LV, Surqwica CM, Greenberg RN, et al. (1995). Prevention of B-lactam-associated diarrhea by Saccharomyces boulardii compared to placebo. Am J gastroenterol 90:439-48. Medline. (Consulta: 4 dic. 2004).
Guandalini S, Pensabene L, Zikri MA, et al. (2000). Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54-60. Medline. (Consulta: 4 dic. 2004).
Shornikova AV, Casas IA, Isolarui E, Mykkanen H, Vesikari T. (1997). Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J pediatr Gastroenterol Nutr 24: 399-404. Medline. (Consulta: 4 dic. 2004).
Brassart D. The use of probiotics to reinforce mucosal defence. Mecechainism. Trends in Food Science & Tecnhnology 1997; 8:321-326.
Saavedra JMN, Bauman A, Oung I. Feeding of Bifidobacterium and Streptococcus Thermophilus to infants in hospital for prevention of diarrhoea and shedding of Rotavirus. Lancet 1994; 344:1046-9.
Reuter G. Das Vorkommen von Laktobazillen in Lebensmitteln und ihr Verhalten immenschlichen Intestinaltrakt. Zentbl. Bakteriol.Parasitol. Infekt. Hyg. I Orig 1965; 197 S: 468-487.
Casas IA, Dobrogosz W J. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb. Ecol. Health Dis 2000; 12: 247-285.
Reuter G. (2001). The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr.Issues Intest. Microbiol 2: 43-53. Medline. (Consulta: 4 dic. 2004).
Wolf BW, Garleb KA, Ataya DG, Casas IA. Safety and tolerance of Lactobacillus reuteri in healthy adult subjects. Microb. Ecol. Health Dis 1995; 8: 41-50.
Wolf BW, Wheeler KB, Ataya DG, Garleb KA. (1998). Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol 36:1085-1094. Medline. (Consulta: 4 dic. 2004).
Shornikova A, Casas IA, Mykkanem H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J 1997; 6: 1103-1107.
Shornikova A, Isolauri E, Casas IA, Mykkanem H, Vesikari T. (1997).Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr.Gastroenterol Nutr 24: 399-404. Medline. (Consulta: 4 dic. 2004).
Vandenplas I. Bacterias y Levaduras en el tratamiento de la diarrea infecciosa aguda y crónica. Clin Microbiol Inf 1999; 5:299-307.
Chandra R. Numerical and functional deficiency in T helper cells in protein- calorie malnutrition. Clin Exp Immunol 1983; 51: 126-32
Gorstein. Assessment of nutritional status using anthropometry. Bull WHO 1994; 72:273-283.
Henriquez G, Hernandez Y, Correa C. Evaluación nutricional antropométrica. Manual de Crecimiento y Desarrollo 1991.p. 16-23
FAO (Food and Agriculture Organization) 2000. Perfiles Nutricionales por Países - Venezuela 2000: 2-6
Schaafsma G. State of the art concerning probiotic strains in milk products. IDF Nutr Newsl 1996; 5:23-4
Varavithya W, Phuapradit P, Vathanaphas K. Prevention of severe rotavirus infection in children receiving bifidobacteria-supplemented formula. World Congress of Pediatric Gastroenterology Hepatology and Nutrition, Boston August 2000. Abstract 995.
Costa-Ribeiro H. Limitations of probiotic therapy in acute, severe dehydratring diarrhea. J. Pediatric Gastroenterol Nutr 2003; 8: 112-5
D?Souza A, Rajkumar C, Cooke J, Bulpitt C. (2002). Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. http://bmj.com/cgi/content/full/324/7350/1361. (Consulta: 4 dic. 2004).
Haschke F, Wang W, Ping G, Varavithya W, Podhipak A, Rochat F, Link-Amster H, Peifer A, Ginsti E, Steenhout P. Clinical Trials prove the safety and efficacy of the probiotic strain Bifidobacterium Bb12 in follow-up formula and growing-up milks. Monatsscr Kinderheilkd 1998: (suppl 1) 146:S26-S30.
Kelleher SL, Casas I, Carbajal N, lonnerdal B. Supplementation of infant formula with the probiotic lactobacillus reuteri and zinc: impact on enteric infetion and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 2002; 35(2): 162-8.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
